LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹21 Cr | ₹13 Cr | ₹12 Cr | ₹-47 Cr | ₹-21 Cr |
What is the latest Net Current Assets ratio of LYKA LABS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹21 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹-47 Cr |
| Mar2021 | ₹-21 Cr |
How is Net Current Assets of LYKA LABS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21 Cr | 61.49 | |
| Mar2024 | ₹13 Cr | 10.99 | |
| Mar2023 | ₹12 Cr | Positive | |
| Mar2022 | ₹-47 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Net Current Assets of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹261.9 Cr | 4.5% | -0.1% | -37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 4.5% |
-0.1% |
-37.1% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses